Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
Ticker Information
Ticker
ADVMCompany Name
ADVERUM BIOTECHNOLOGIES INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQADVERUM BIOTECHNOLOGIES INC - Price to Book Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
ADVM - P/B Historical data
| Date | Shareholders Equity | Market Capitalization | Price to Book |
|---|---|---|---|
| 6/30/2025 | $ -20.22M | $ 51.83M | 0 |
| 3/31/2025 | $ 26.42M | $ 43.03M | 1.63 |
| 12/31/2024 | $ 70.71M | $ 67.48M | 0.95 |
| 9/30/2024 | $ 144.12M | $ 156.85M | 1.09 |
| 6/30/2024 | $ 168.03M | $ 135M | 0.8 |
| 3/31/2024 | $ 182.29M | $ 199.47M | 1.09 |
| 12/31/2023 | $ 83.47M | $ 367.36M | 4.4 |
| 9/30/2023 | $ 102.71M | $ 91.93M | 0.9 |
| 6/30/2023 | $ 131.16M | $ 184.82M | 1.41 |
| 3/31/2023 | $ 157.76M | $ 84.48M | 0.54 |
Key Performance Insights, Last 5 Years
- ADVERUM BIOTECHNOLOGIES INC's latest trailing twelve months (TTM) P/B stands at 2.55.
- Over the past 5 years, ADVERUM BIOTECHNOLOGIES INC's average P/B has been 1.19.
- The median P/B for ADVERUM BIOTECHNOLOGIES INC during this period was 0.87
- ADVERUM BIOTECHNOLOGIES INC reached its highest P/B over the past 5 years at 4.4.
- The lowest P/B recorded by ADVERUM BIOTECHNOLOGIES INC in the same timeframe 0.32
ADVERUM BIOTECHNOLOGIES INC's P/B vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
P/B Benchmarks
Similar metrics to P/B:
- Price to Sales - [Calculation] Measures a company’s [MarketCap] in relation to its [Revenue].
- Free Cash Flow Yield - [Calculation] The Free Cash Flow Yield, also known as the inverse of the Price to Free Cash Flow ratio [PFCF], expresses a company’s Free Cash Flow [FCF] as a percentage of [MarketCap.
- Price to Free Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Free Cash Flow [FCF].
- Price to Operating Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Operating Cash Flow [NCFO].
- Shareholders Equity - [Balance Sheet] A principal component of the balance sheet; in addition to [Liabilities] and [Assets]; that represents the total of all stockholders' equity (deficit) after all liabilities have been deducted.
Definition of Price to Book
[Calculation] Measures a company’s [MarketCap] in relation to its [Equity] which is the value of [Assets] minus [Liabilities].Market Cap / Equity
(=) P/B P/B for ADVERUM BIOTECHNOLOGIES INC is calculated as follows: Market Cap [ $ 1.19B ] / Equity [ $ 464.71M ]
(=) P/B [ 2.55 ] ADVM - Price to Book, Last 5 years
0.32
Minimum
Mar 31, 2022
4.4
Maximum
Dec 31, 2023
1.19
Average
0.87
Median
P/B Benchmark AnalysisMarket
The chart above depicts the distribution of P/B for companies in the Total Stock Market. The average P/B of the companies is 2.3 with a standard deviation of 1.81.
The following table provides additional summary stats:
P/B in the Market:
| filtered constituents | 3.36K |
|---|---|
| min | 0 |
| max | 8.04 |
| average | 2.3 |
| median | 1.63 |
| std | 1.81 |